FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Fisher

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Steven P LaRosa; Steven M Opal; Barbara G Utterback; Sau Chi Betty Yan; Jeffrey D Helterbrand; Andrew J H Simpson; Wipada Chaowagul; Nicholas J White; Charles J Fisher
Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.
gordon bernard; Jean-Louis Vincent; Pierre-François Laterre; Steven P LaRosa; Jean-François Dhainaut; A Lopez-Rodriguez; Jay S Steingrub; Gary E Garber; Jeffrey D Helterbrand; E Wesley Ely; Charles J Fisher
Efficacy and safety of recombinant human activated protein C for severe sepsis.
Edward Abraham; M A Matthay; Charles A Dinarello; Jean-Louis Vincent; J Cohen; Steven M Opal; M Glauser; P Parsons; Charles J Fisher; John Repine
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Fisher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Steven P LaRosa; Steven M Opal; Barbara G Utterback; Sau Chi Betty Yan; Jeffrey D Helterbrand; Andrew J H Simpson; Wipada Chaowagul; Nicholas J White; Charles J Fisher
Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2006;10(1):25-31.
2001: gordon bernard; Jean-Louis Vincent; Pierre-François Laterre; Steven P LaRosa; Jean-François Dhainaut; A Lopez-Rodriguez; Jay S Steingrub; Gary E Garber; Jeffrey D Helterbrand; E Wesley Ely; Charles J Fisher
Efficacy and safety of recombinant human activated protein C for severe sepsis.
The New England journal of medicine 2001;344(10):699-709.
2000: Edward Abraham; M A Matthay; Charles A Dinarello; Jean-Louis Vincent; J Cohen; Steven M Opal; M Glauser; P Parsons; Charles J Fisher; John Repine
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation.
Critical care medicine 2000;28(1):232-5.
1997: Steven M Opal; Charles J Fisher; Jean-François Dhainaut; Jean-Louis Vincent; R Brase; Stephen Lowry; J C Sadoff; Gus J Slotman; Howard Levy; R A Balk; M P Shelly; John P Pribble; J F LaBrecque; J Lookabaugh; H Donovan; H Dubin; R Baughman; J Norman; E DeMaria; K Matzel; Edward Abraham; Michael G Seneff
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
Critical care medicine 1997;25(7):1115-24.
1997: Charles L Sprung; Leonid A Eidelman; Reuven Pizov; Charles J Fisher; Elizabeth J Ziegler; J C Sadoff; R C Straube; R V McCloskey
Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study Group.
Critical care medicine 1997;25(3):383-7.
1996: Charles J Fisher; J M Agosti; Steven M Opal; Stephen F Lowry; RA Balk; J C Sadoff; Edward Abraham; Roland M H Schein; E Benjamin
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.
The New England journal of medicine 1996;334(26):1697-702.
1996: Charles J Fisher; Y Zheng
Potential strategies for inflammatory mediator manipulation: retrospect and prospect.
World journal of surgery 1996;20(4):447-53.
1996: William A Knaus; Frank E Harrell; J F LaBrecque; Douglas P Wagner; John P Pribble; E A Draper; Charles J Fisher; L Soll
Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group.
Critical care medicine 1996;24(1):46-56.
1994: Charles J Fisher; Steven M Opal; Stephen F Lowry; J C Sadoff; J F LaBrecque; H C Donovan; J L Lookabaugh; J Lemke; John P Pribble; S C Stromatt
Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis.
Circulatory shock 1994;44(1):1-8.
1994: Daniel H Kett; Andrew Quartin; Charles L Sprung; Charles J Fisher; M A Peña; S O Heard; J L Zimmerman; Timothy E Albertson; Edward A Panacek; Leonid A Eidelman
An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody.
Critical care medicine 1994;22(8):1227-34.
1994: Charles J Fisher; J F Dhainaut; Steven M Opal; John P Pribble; RA Balk; Gus J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
JAMA : the journal of the American Medical Association 1994;271(23):1836-43.
1994: Charles J Fisher; Gus J Slotman; Steven M Opal; John P Pribble; R C Bone; G Emmanuel; D Ng; D C Bloedow; M A Catalano
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.
Critical care medicine 1994;22(1):12-21.
1993: William A Knaus; Frank E Harrell; Charles J Fisher; Douglas P Wagner; Steven M Opal; J C Sadoff; E A Draper; Cynthia A Walawander; K Conboy; T H Grasela
The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis.
JAMA : the journal of the American Medical Association 1993;270(10):1233-41.
1993: Charles J Fisher; Steven M Opal; J F Dhainaut; S Stephens; J L Zimmerman; P Nightingale; S J Harris; Roland M H Schein; Edward A Panacek; J L Vincent
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group.
Critical care medicine 1993;21(3):318-27.
1993: Gus J Slotman; Charles J Fisher; R C Bone; Terry P Clemmer; C A Metz
Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group.
Critical care medicine 1993;21(2):191-5.
1992: Terry P Clemmer; Charles J Fisher; R C Bone; Gus J Slotman; C A Metz; F O Thomas
Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group.
Critical care medicine 1992;20(10):1395-401.
1991: Elizabeth J Ziegler; Charles J Fisher; C L Sprung; Richard C Straube; J C Sadoff; G E Foulke; C H Wortel; Mitchell Fink; R Phillip Dellinger; N N Teng
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
The New England journal of medicine 1991;324(7):429-36.
1990: Charles J Fisher; J Zimmerman; Muhammad B Khazaeli; Timothy E Albertson; R Phillip Dellinger; Edward A Panacek; G E Foulke; C Dating; C R Smith; A F LoBuglio
Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.
Critical care medicine 1990;18(12):1311-5.
1989: W F Rutherford; Edward A Panacek; J K Griffith; J A Green; Mark A Munger; E Bednarczyk; FD Miraldi; Charles J Fisher
Prediction of changing cerebral blood flow by use of the conjunctival oxygen tension/arterial oxygen tension index.
Critical care medicine 1989;17(12):1328-32.
1989: R C Bone; Charles J Fisher; Terry P Clemmer; Gus J Slotman; C A Metz; RA Balk
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Critical care medicine 1989;17(5):389-93.
1987: R C Bone; Charles J Fisher; Terry P Clemmer; GUS SLOTMAN; C A Metz; RA Balk
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
The New England journal of medicine 1987;317(11):653-8.
1987: W F Rutherford; Timothy E Albertson; Edward A Panacek; J Mogannam; Charles J Fisher
Deterioration of conjunctival PO2 after CPR.
Annals of emergency medicine 1987;16(8):894-7.
1986: G E Foulke; Timothy E Albertson; Charles J Fisher
Critical care medicine: an annotated bibliography of the recent literature.
The American journal of emergency medicine 1986;4(5):470-80.
1985: G E Foulke; Timothy E Albertson; Charles J Fisher
Critical care medicine: an annotated bibliography of the recent literature.
The American journal of emergency medicine 1985;3(3):266-74.
1985: Charles J Fisher; Timothy E Albertson; G E Foulke
Salicylate-induced pulmonary edema: clinical characteristics in children.
The American journal of emergency medicine 1985;3(1):33-7.
1984: G E Foulke; Charles J Fisher; R H Demling
Effect of nitroprusside administration and sudden withdrawal on pulmonary vascular tone and lung fluid balance.
Critical care medicine 1984;12(5):432-5.
1982: G E Foulke; Charles J Fisher; R H Demling
Effect of nitroprusside on pulmonary hypertension and lung fluid balance after E. coli endotoxin.
Critical care medicine 1982;10(7):427-31.